Central Nervous System Therapeutics Market to Reach $199.09 Billion, Globally By 2033 | CAGR 5.7%: Allied Market Research
February 23, 2024 08:47 ET
|
Allied Analytics LLP
Wilmington, New Castle, Delaware, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Central Nervous System (CNS) Therapeutics Market by Disease Type...
Sales Revenue from CNS Therapeutics Market to Top US$ 142.1 Billion by 2026: Fact.MR Analysis
March 23, 2023 10:00 ET
|
FACT.MR
Rockville, March 23, 2023 (GLOBE NEWSWIRE) -- In 2022, the CNS therapeutics market is valued at US$ 116.7 Bn, and is projected to evolve at a CAGR of 4.9% over the 2022 to 2026 forecast period,...
Global CNS Therapeutics Market is expected to reach US$ 133.2 Billion in 2026: Visiongain Research Inc
March 28, 2022 09:00 ET
|
Visiongain Ltd
Visiongain has published a new report on “CNS Therapeutics Market Forecast, 2021-2031”. Forecasts by Disease (Neurovascular Disease, Trauma, Mental Health, Degenerative, Others), End Use (Hospitals,...